Zurich Cantonal Bank’s Definium Therapeutics DFTX Stock Holding History

Zurich Cantonal Bank’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Buy	32,394 +11,526	+55%	+$285K	﹤0.01%	1288
2026 Q1	$394K	Buy	20,868 +5,751	+38%	+$97.6K	﹤0.01%	1947
2025 Q4	$202K	Hold	15,117	–	–	﹤0.01%	2218
2025 Q3	$178K	Sell	15,117 -485	-3%	-$4.52K	﹤0.01%	2245
2025 Q2	$101K	Sell	15,602 -13,265	-46%	-$87.2K	﹤0.01%	2376
2025 Q1	$169K	Buy	28,867 +1,669	+6%	+$12K	﹤0.01%	2180
2024 Q4	$189K	Buy	27,198 +4,972	+22%	+$34.2K	﹤0.01%	2173
2024 Q3	$126K	Buy	22,226 +4,079	+22%	+$28.4K	﹤0.01%	2337
2024 Q2	$131K	Buy	+18,147	New	+$159K	﹤0.01%	2253

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Zurich Cantonal Bank's DFTX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Definium Therapeutics (DFTX) stake by 55% in Q2 2026, buying an estimated $285K and bringing the position to 32,394 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

Zurich Cantonal Bank first reported a position in DFTX in Q2 2024 and has held it in 9 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Zurich Cantonal Bank held 32,394 shares of Definium Therapeutics worth $1.52M as of Q2 2026.
Zurich Cantonal Bank bought 11,526 Definium Therapeutics shares in Q2 2026, an estimated $285K.
Definium Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1288 holding.
Zurich Cantonal Bank first reported a position in Definium Therapeutics in Q2 2024 and has held it in 9 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.